Lunit jumps 26% on KOSDAQ after collaboration with US company
Predicted impact: Low
Collaboration with a US firm; no contract value given, only a share price jump.
Lunit루닛
328130 · KOSDAQ · ₩328130 · 루닛
₩14,690▲ ₩3,390 (30.00%)End-of-day · Oct 26, 2026 · End-of-day prices.
Price · 1Y −26.55%
- Market cap
- ₩1.1T
- Enterprise value
- ₩1T
- P/E
- —
- P/B
- 3.3×
- Dividend yield
- 0.0%
- ROE
- −16.8%
- Net margin
- −60.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−41.1% from the high
₩8,180Today: ₩12,150 – ₩14,690₩24,930
Returns
- 1W+13.1%
- 1M+49.7%
- 3M+52.9%
- 6M−23.2%
- YTD−28.6%
- 1Y−25.0%
- Volume today
- 4,183,481
- 3.7× the 20-day average
- Traded today
- ₩59B
- Listed shares
- 74,458,180
- EPS (12 months)
- −₩748
- Earnings yield −5.1%
AI research · InitiationLunit: Revenue Growing Fast, Losses Persist, Shares Rebound 44.2% in a MonthThe data shows a company with fast revenue growth and improving margins but still large losses and cash outflows.Read the full report →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
+30.0% on Oct 26, 2026. Trading value 4.6× its normal.
Lunit shares jumped 26% on the KOSDAQ market after the company announced a collaboration with a US company. Separately, Lunit is working with Summit on analysing ibonecimab using AI.
AI summary of the news and filings linked. It can be wrong; check them.
- • Foreign investors bought a net ₩2.8B that day
- • Buzz 69 on JONBUR: heavy trading
Possible reasons, not certainties. Not financial advice.
Signals
Warming up- BuzzRisingBuzz 69: heavy trading.
- SentimentPositiveNews: Headlines report a sharp share price rise tied to a new collaboration. Community: 0 bullish, 0 bearish posts this week.
- MomentumStrong40.6% over the last month; the price is above its 20-day average.
- News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Oct 26: sell ₩520M at the close (3.9% of 20-day average trading value)
On its 30 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 19.9% of trading value and pointed the same way 21 of 30 times.
- 2× KODEX KOSDAQ150 Leverage −₩438M
- -1× KODEX KOSDAQ150 Futures Inverse −₩37M
- 2× TIGER KOSDAQ150 Leverage −₩32M
- 2× RISE KOSDAQ150 Futures Leverage −₩9.3M
- -1× TIGER KOSDAQ150 Futures Inverse −₩1M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
ETFs holding this
All ETFs →Held by 11 funds.
- KODEX KOSDAQ1500.4%
- KODEX KOSDAQ150 Leverage2×0.4%
- TIGER KOSDAQ1500.4%
- RISE KOSDAQ1500.4%
- ACE KOSDAQ 1500.4%
- TIGER KOSDAQ150 Leverage2×0.4%
- KIWOOM KOSDAQ1500.4%
- SOL KOSDAQ1500.4%
Estimated from the funds' index or underlying stock.
Lunit stock overview
Lunit (루닛, KRX: 328130) is listed on KOSDAQ, in the Software sector. Lunit is a Korean deep-learning medical AI company founded in 2013 that focuses on medical imaging, particularly cancer diagnosis. Its shares closed at ₩14,690 on Oct 26, 2026, up 30.00% on the day, giving it a market value of ₩1.1T.
Key facts
- Market cap
- ₩1.1T
- Sector
- Software
- Latest price change
- +30.00%
- As of
- Oct 26, 2026
- Main business
- Lunit is a Korean deep-learning medical AI company founded in 2013 that focuses on medical imaging, particularly cancer diagnosis.
Quick answers about Lunit
- What does Lunit do?
- Lunit is a Korean deep-learning medical AI company founded in 2013 that focuses on medical imaging, particularly cancer diagnosis. Its main products include Lunit INSIGHT, which assists radiologists in detecting abnormalities in chest X-rays, mammography and digital breast tomosynthesis images, and Lunit SCOPE, which quantifies biomarkers from digital pathology slides and predicts immunotherapy response for oncology research and drug development. Its customers include medical institutions and global partners such as GE Healthcare, Philips, Fujifilm and Hologic, as well as pharmaceutical companies, with sales mostly outside Korea and operations in the United States, Japan, Australia and Canada.
- What is the market cap of Lunit?
- The market capitalisation of Lunit was ₩1.1T at the close on Oct 26, 2026.
- Who are the largest shareholders of Lunit?
- According to the latest official filings, the largest reported holders are Baek Seung-wook (8.80%, as of Jun 30, 2026); Samsung Asset Management (4.12%, as of May 7, 2026); VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND (3.17%, as of Jul 31, 2026).
- When is the next earnings report from Lunit?
- Korean companies rarely announce results dates in advance. Based on when Lunit filed the same report in past years, its next 3q results is expected around Nov 13, 2026.
- Does the National Pension Service own Lunit?
- Yes. The National Pension Service held 1.21% of Lunit shares as of Dec 31, 2025.
Company profile
Lunit is a Korean deep-learning medical AI company founded in 2013 that focuses on medical imaging, particularly cancer diagnosis. Its main products include Lunit INSIGHT, which assists radiologists in detecting abnormalities in chest X-rays, mammography and digital breast tomosynthesis images, and Lunit SCOPE, which quantifies biomarkers from digital pathology slides and predicts immunotherapy response for oncology research and drug development. Its customers include medical institutions and global partners such as GE Healthcare, Philips, Fujifilm and Hologic, as well as pharmaceutical companies, with sales mostly outside Korea and operations in the United States, Japan, Australia and Canada.
Written by AI from the company's latest annual report.
- Korean name
- 루닛
- Sector
- Software
- CEO
- 서범석
- Founded
- Aug 2013
- Listed
- Jul 2022
- Listed shares
- 74,458,180
- Fiscal year ends
- Month 12
- Website
- www.lunit.io
Similar companies
- Hyundai Autoever307950 · ₩8.6T₩312,500−3.70%
- Krafton259960 · ₩8.4T₩183,500−1.13%
- NC036570 · ₩4.3T₩201,500−1.71%
- Netmarble251270 · ₩2.8T₩33,550−1.32%
- PearlAbyss263750 · ₩2.2T₩34,350−0.72%
- Shift UP462870 · ₩1.7T₩29,450−2.64%
- NHN181710 · ₩1.6T₩49,100−4.29%
- Kakao Games293490 · ₩1.2T₩11,200−3.03%
Recent news
Lunit Analyzes Ibonecimab with Summit Using AI
Predicted impact: Low
AI analysis collaboration with no contract value or financial size given.
Recent filings
See all- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before MaturityOct 2, 2026
- Adjustment of Conversion PriceOct 1, 2026
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before MaturitySep 28, 2026
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before MaturitySep 23, 2026
- Adjustment of Conversion PriceSep 4, 2026
Titles in Korean until English translations are added.
Also known as: Lunit / 루닛 / 328130 / KRX:328130
Source: KRX statistical information